Another study by Li et al. reported that tumour growth was reduced in CCL2 null mutant mice, and anti-CCL2 antibody treatment reduced pulmonary metastasis in mice bearing mammary tumours, supporting the role of CCL2 in tumour promotion [59]. Here, CCL2 is linked to breast cancer.